5Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications [ J ]. J Am Soc Nephrol,2002, 13 Suppl 1 :S37-S40.
6Retnakaran R, Cull CA, Thorne KI,et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74 [ J ]. Diabetes,2006,55 (6) : 1832-1839.
7Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding pro- tein as a bioInarker of acute kidney injury after cardiac surgery [J]. Kidney lnt, 2008, 73(4) : 465-472.
8Kamijo-Ikemori A, Sugaya T. Urinary liver type fatty acid binding protein (L-FABP) [ J]. Nibon Rinsho,2010,68 Suppl 9 :406409.
9Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kid- ney injury[J]. Kidney Int, 2010,77(8) :708-714.
10Sasaki H, Kamijo-rkemori A, Sugaya T, et al. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy [J].Nephron Clin Pract ,2009,112 ( 3 ) : e148-c1 56.
